Aldometanib
Aldometanib (LXY-05-029) is an orally bioavailable small molecule that inhibits aldolase, disrupting its interaction with v-ATPase and FBP to activate lysosomal AMPK. This mechanism supports its application in research models investigating metabolic regulation and homeostasis, both in cellular and animal studies.
Product Specifications
CAS Number
2904601-67-6
Product Name Alternative
Compound IA-47, Compound IA-47 (Br- base 2246625-81-8), CompoundIA47, Br- base 2246625-81-8, aldolase, Aldometanib
Field of Research
Epigenetics & Chromatin, Signal Transduction
Purity
98.80% (May vary between batches)
Solubility
DMSO:131.25 mg/mL (221.16 mM)
Smiles
CC1=[N+] (C=CN1CCCCCCCCCCCCCCCC) CC2=C (Cl) C=CC=C2Cl.[I-]
Molecular Formula
C27H43Cl2IN2
Molecular Weight
593.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
030927-PE 100 µL
DYRK2 (DYRK2, Dual specificity tyrosine-phosphorylation-regulated kinase 2) (PE) discontinued
Sign In for Pricing
View Details 
TRV-0031436 96 Tests
Multiplex Assay Kit for DNA Damage Inducible Transcript 3 (DDIT3)
Sign In for Pricing
View Details